vs

Side-by-side financial comparison of Enact Holdings, Inc. (ACT) and Astera Labs, Inc. (ALAB). Click either name above to swap in a different company.

Enact Holdings, Inc. is the larger business by last-quarter revenue ($312.7M vs $270.6M, roughly 1.2× Astera Labs, Inc.). On growth, Astera Labs, Inc. posted the faster year-over-year revenue change (91.8% vs 3.6%). Over the past eight quarters, Astera Labs, Inc.'s revenue compounded faster (103.6% CAGR vs 3.6%).

Enact Holdings, Inc. is a leading U.S.-based private mortgage insurance provider. It delivers risk mitigation solutions to residential mortgage lenders, banks, and credit unions, enabling borrowers with smaller down payments to access affordable home financing, and supports sustainable homeownership for diverse consumer groups across the United States.

Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.

ACT vs ALAB — Head-to-Head

Bigger by revenue
ACT
ACT
1.2× larger
ACT
$312.7M
$270.6M
ALAB
Growing faster (revenue YoY)
ALAB
ALAB
+88.2% gap
ALAB
91.8%
3.6%
ACT
Faster 2-yr revenue CAGR
ALAB
ALAB
Annualised
ALAB
103.6%
3.6%
ACT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACT
ACT
ALAB
ALAB
Revenue
$312.7M
$270.6M
Net Profit
$45.0M
Gross Margin
75.6%
Operating Margin
71.3%
24.7%
Net Margin
16.6%
Revenue YoY
3.6%
91.8%
Net Profit YoY
82.0%
EPS (diluted)
$1.23
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACT
ACT
ALAB
ALAB
Q4 25
$312.7M
$270.6M
Q3 25
$311.5M
$230.6M
Q2 25
$304.9M
$191.9M
Q1 25
$306.8M
$159.4M
Q4 24
$301.8M
$141.1M
Q3 24
$309.6M
$113.1M
Q2 24
$298.8M
$76.8M
Q1 24
$291.6M
$65.3M
Net Profit
ACT
ACT
ALAB
ALAB
Q4 25
$45.0M
Q3 25
$91.1M
Q2 25
$51.2M
Q1 25
$31.8M
Q4 24
$24.7M
Q3 24
$-7.6M
Q2 24
$-7.5M
Q1 24
$-93.0M
Gross Margin
ACT
ACT
ALAB
ALAB
Q4 25
75.6%
Q3 25
76.2%
Q2 25
75.8%
Q1 25
74.9%
Q4 24
74.0%
Q3 24
77.7%
Q2 24
77.9%
Q1 24
77.4%
Operating Margin
ACT
ACT
ALAB
ALAB
Q4 25
71.3%
24.7%
Q3 25
67.4%
24.0%
Q2 25
70.4%
20.7%
Q1 25
68.9%
7.1%
Q4 24
68.9%
0.1%
Q3 24
74.1%
-7.9%
Q2 24
78.6%
-31.7%
Q1 24
70.6%
-127.1%
Net Margin
ACT
ACT
ALAB
ALAB
Q4 25
16.6%
Q3 25
39.5%
Q2 25
26.7%
Q1 25
20.0%
Q4 24
17.5%
Q3 24
-6.7%
Q2 24
-9.8%
Q1 24
-142.5%
EPS (diluted)
ACT
ACT
ALAB
ALAB
Q4 25
$1.23
$0.25
Q3 25
$1.10
$0.50
Q2 25
$1.11
$0.29
Q1 25
$1.08
$0.18
Q4 24
$1.05
$1.23
Q3 24
$1.15
$-0.05
Q2 24
$1.16
$-0.05
Q1 24
$1.01
$-1.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACT
ACT
ALAB
ALAB
Cash + ST InvestmentsLiquidity on hand
$582.5M
$167.6M
Total DebtLower is stronger
$744.5M
Stockholders' EquityBook value
$5.4B
$1.4B
Total Assets
$6.9B
$1.5B
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACT
ACT
ALAB
ALAB
Q4 25
$582.5M
$167.6M
Q3 25
$545.6M
$140.4M
Q2 25
$616.0M
$162.3M
Q1 25
$639.0M
$86.4M
Q4 24
$602.8M
$79.6M
Q3 24
$674.9M
$126.1M
Q2 24
$711.3M
$421.1M
Q1 24
$624.3M
$696.1M
Total Debt
ACT
ACT
ALAB
ALAB
Q4 25
$744.5M
Q3 25
$744.1M
Q2 25
$743.8M
Q1 25
$743.4M
Q4 24
$743.0M
Q3 24
$742.7M
Q2 24
$742.4M
Q1 24
$746.1M
Stockholders' Equity
ACT
ACT
ALAB
ALAB
Q4 25
$5.4B
$1.4B
Q3 25
$5.3B
$1.3B
Q2 25
$5.2B
$1.1B
Q1 25
$5.1B
$1.0B
Q4 24
$5.0B
$964.8M
Q3 24
$5.0B
$889.6M
Q2 24
$4.8B
$845.3M
Q1 24
$4.7B
$808.8M
Total Assets
ACT
ACT
ALAB
ALAB
Q4 25
$6.9B
$1.5B
Q3 25
$6.9B
$1.4B
Q2 25
$6.8B
$1.3B
Q1 25
$6.7B
$1.1B
Q4 24
$6.5B
$1.1B
Q3 24
$6.6B
$983.1M
Q2 24
$6.3B
$915.5M
Q1 24
$6.3B
$864.9M
Debt / Equity
ACT
ACT
ALAB
ALAB
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.14×
Q1 25
0.15×
Q4 24
0.15×
Q3 24
0.15×
Q2 24
0.15×
Q1 24
0.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACT
ACT
ALAB
ALAB
Operating Cash FlowLast quarter
$724.5M
$95.3M
Free Cash FlowOCF − Capex
$76.6M
FCF MarginFCF / Revenue
28.3%
Capex IntensityCapex / Revenue
6.9%
Cash ConversionOCF / Net Profit
2.12×
TTM Free Cash FlowTrailing 4 quarters
$281.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACT
ACT
ALAB
ALAB
Q4 25
$724.5M
$95.3M
Q3 25
$192.0M
$78.2M
Q2 25
$119.5M
$135.4M
Q1 25
$226.7M
$10.5M
Q4 24
$686.3M
$39.7M
Q3 24
$188.1M
$63.5M
Q2 24
$144.7M
$29.8M
Q1 24
$187.3M
$3.7M
Free Cash Flow
ACT
ACT
ALAB
ALAB
Q4 25
$76.6M
Q3 25
$65.9M
Q2 25
$133.3M
Q1 25
$6.0M
Q4 24
$24.3M
Q3 24
$46.8M
Q2 24
$28.5M
Q1 24
$228.0K
FCF Margin
ACT
ACT
ALAB
ALAB
Q4 25
28.3%
Q3 25
28.6%
Q2 25
69.5%
Q1 25
3.7%
Q4 24
17.2%
Q3 24
41.4%
Q2 24
37.1%
Q1 24
0.3%
Capex Intensity
ACT
ACT
ALAB
ALAB
Q4 25
6.9%
Q3 25
5.3%
Q2 25
1.1%
Q1 25
2.8%
Q4 24
10.9%
Q3 24
14.8%
Q2 24
1.7%
Q1 24
5.2%
Cash Conversion
ACT
ACT
ALAB
ALAB
Q4 25
2.12×
Q3 25
0.86×
Q2 25
2.64×
Q1 25
0.33×
Q4 24
1.61×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons